Reply to: “Incidence of Jarisch–Herxheimer reaction after syphilis treatment and the role of awareness effect” Authors: Hung-Chin Tsai Published: 2026 DEAR EDITOR, We thank Dr. Ono et al1 for their valuable comments regarding our study, named “Increased serum APOC3 in patients with syphilis can predict the absence of Jarisch-Herxheimer reaction after benzathine penicillin treatment,” published in Journal of the Chinese Medical Association in June 2025.2 The author’s comments are discussed below. They raise the importance of structured pretreatment explanations for better identifying the incidence of Jarisch–Herxheimer reaction (JHR) in patients with syphilis receiving penicillin treatment. In their analysis, they identified an increased incidence of JHR after the implementation of reinforced explanation, although the case numbers are so small (six patients). They concluded they were unlikely due to solely to a noceno effect because all of the six patients had a fever of more than 37.5°C. The causes of JHR are unclear. One possibility is that the morphology of dividing spirochaetes was changed due to penicillin treatment and then making them more susceptible to phagocytosis. Another possibility was that the cytokine-associated JHR was released by the dysmorphic spirochaetes.3 In their study, they did not mention using any Treponema palladium polymerase chain reaction and cytokines to better analyze the association of JHR and immune factors. They also did not mention the sensitivity or specific for those pretreatment explanation factors. The underestimated incidence of JHR in early syphilis patients proposed by the author needs to be concluded carefully.